silybin has been researched along with novobiocin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Blagg, BS; Brandt, GE; Galam, L; Matts, RL; Zhao, H | 1 |
| Dyson, HJ; McAlpine, SR; McConnell, JR | 1 |
| Blagg, BS; Forsberg, LK; Hall, JA | 1 |
| Bosch-Barrera, J; Cuyàs, E; Encinar, JA; Joven, J; Menendez, JA; Micol, V; Verdura, S | 1 |
5 other study(ies) available for silybin and novobiocin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Identification and initial SAR of silybin: an Hsp90 inhibitor.
Topics: Cell Line, Tumor; Drug Design; HSP90 Heat-Shock Proteins; Humans; Molecular Structure; Silybin; Silymarin; Structure-Activity Relationship | 2011 |
Using NMR to identify binding regions for N and C-terminal Hsp90 inhibitors using Hsp90 domains.
Topics: | 2021 |
Alternative approaches to Hsp90 modulation for the treatment of cancer.
Topics: Animals; Antineoplastic Agents; Catechin; Drug Discovery; HSP90 Heat-Shock Proteins; Humans; Models, Molecular; Neoplasms; Novobiocin; Silybin; Silymarin | 2014 |
Revisiting silibinin as a novobiocin-like Hsp90 C-terminal inhibitor: Computational modeling and experimental validation.
Topics: Antineoplastic Agents; Binding Sites; Cyclophilins; Hep G2 Cells; HSP90 Heat-Shock Proteins; Humans; Molecular Docking Simulation; Novobiocin; Protein Binding; Protein Multimerization; Silybin; Superoxides | 2019 |